I'll just finish by asking, “To what end?” I think that's the question we'd have to ask. Is it really a necessary thing, or would it simply complicate matters? I don't know.
On October 23rd, 2012. See this statement in context.
On October 23rd, 2012. See this statement in context.
October 23rd, 2012 / 12:45 p.m.
Chief of Staff and Vice-President, Legal Affairs, Canada's Research-Based Pharmaceutical Companies (Rx&D)
I'll just finish by asking, “To what end?” I think that's the question we'd have to ask. Is it really a necessary thing, or would it simply complicate matters? I don't know.
See context to find out what was said next.